Methods related to engineered Fc constructs
US-12391759-B2 · Aug 19, 2025 · US
This page is not indexed by search engines while we improve data quality.
Ling Leona E patents
Ling Leona E is listed as an inventor on 35 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Ling Leona E |
| Total patents | 35 |
| First publication | Mar 31, 2016 |
| Latest publication | Aug 19, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Methods for the treatment of neurodegeneration
US-12297256-B2 · May 13, 2025 · US
COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
US-2025011432-A1 · Jan 9, 2025 · US
Compositions and methods related to engineered Fc constructs
US-12071482-B2 · Aug 27, 2024 · US
FcRn Antibodies and Methods of Use Thereof
US-2024158508-A1 · May 16, 2024 · US
Fcrn antibodies and methods of use thereof
US-2024158509-A1 · May 16, 2024 · US
Sialylated Glycoproteins
US-2024052040-A1 · Feb 15, 2024 · US
FcRn antibodies and methods of use thereof
US-11773168-B2 · Oct 3, 2023 · US
FcRn antibodies and methods of use thereof
US-11732047-B2 · Aug 22, 2023 · US
Sialylated glycoproteins
US-11661456-B2 · May 30, 2023 · US
Recent patents
Latest publications not already listed above.
FcRn Antibodies and Methods of Use Thereof
US-2023049725-A1 · Feb 16, 2023 · US
Methods For The Treatment Of Neurodegeneration
US-2022267413-A1 · Aug 25, 2022 · US
Methods for the treatment of neurodegeneration
US-11352415-B2 · Jun 7, 2022 · US
FcRn antibodies and methods of use thereof
US-11345751-B2 · May 31, 2022 · US
METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
US-2022153833-A1 · May 19, 2022 · US
FcRn Antibodies and Methods of Use Thereof
US-2022064290-A1 · Mar 3, 2022 · US
COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
US-2022033499-A1 · Feb 3, 2022 · US
Compositions and methods related to engineered Fc constructs
US-11124573-B2 · Sep 21, 2021 · US
FcRn Antibodies and Methods of Use Thereof
US-2021238275-A1 · Aug 5, 2021 · US
Methods and Compositions for the Diagnosis and Treatment of Kawasaki Disease
US-2021116462-A1 · Apr 22, 2021 · US
FcRn Antibodies and Methods of Use Thereof
US-2020299382-A1 · Sep 24, 2020 · US
FcRn antibodies and methods of use thereof
US-10676526-B2 · Jun 9, 2020 · US
Sialylated Glycoproteins
US-2020087402-A1 · Mar 19, 2020 · US
Methods For The Treatment Of Neurodegeneration
US-2020055921-A1 · Feb 20, 2020 · US
Methods for the treatment of neurodegeneration
US-10464996-B2 · Nov 5, 2019 · US
COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
US-2019225688-A1 · Jul 25, 2019 · US
Compositions and methods related to engineered Fc constructs
US-10239944-B2 · Mar 26, 2019 · US
Therapeutic and Diagnostic Methods for Autoimmune Diseases and/or Inflammation
US-2019048417-A1 · Feb 14, 2019 · US
Sialylated Glycoproteins
US-2018327498-A1 · Nov 15, 2018 · US
Fcrn antibodies and methods of use thereof
US-2018016334-A1 · Jan 18, 2018 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Momenta Pharmaceuticals Inc | 34 |
| Janssen Biotech Inc | 2 |
| Momenta Pharmaceuticals Inc | 1 |
| Bosques Carlos J | 1 |
| Huston James S | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K2039/505 | 22 |
| C07K16/283 | 21 |
| C07K16/00 | 21 |
| A61P37/02 | 19 |
| C07K2317/41 | 19 |